Operating Lease, Right-of-Use Asset in USD of Rani Therapeutics Holdings, Inc. from Q4 2021 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Rani Therapeutics Holdings, Inc. quarterly Operating Lease, Right-of-Use Asset history and change rate from Q4 2021 to Q3 2025.
  • Rani Therapeutics Holdings, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $4,017,000, a 26% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Rani Therapeutics Holdings, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $4,017,000 -$1,410,000 -26% 30 Sep 2025 10-Q 06 Nov 2025 2025 Q3
Q2 2025 $4,388,000 -$1,363,000 -24% 30 Jun 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 $4,748,000 -$1,223,000 -20% 31 Mar 2025 10-Q 13 May 2025 2025 Q1
Q4 2024 $5,096,000 +$4,378,000 +610% 31 Dec 2024 10-Q 06 Nov 2025 2025 Q3
Q3 2024 $5,427,000 +$4,468,000 +466% 30 Sep 2024 10-Q 14 Nov 2024 2024 Q3
Q2 2024 $5,751,000 +$4,557,000 +382% 30 Jun 2024 10-Q 06 Aug 2024 2024 Q2
Q1 2024 $5,971,000 +$4,548,000 +320% 31 Mar 2024 10-Q 06 May 2024 2024 Q1
Q4 2023 $718,000 -$347,000 -33% 31 Dec 2023 10-K 31 Mar 2025 2024 FY
Q3 2023 $959,000 -$343,000 -26% 30 Sep 2023 10-Q 08 Nov 2023 2023 Q3
Q2 2023 $1,194,000 +$195,000 +20% 30 Jun 2023 10-Q 11 Aug 2023 2023 Q2
Q1 2023 $1,423,000 +$264,000 +23% 31 Mar 2023 10-Q 10 May 2023 2023 Q1
Q4 2022 $1,065,000 +$1,065,000 31 Dec 2022 10-K 20 Mar 2024 2023 FY
Q3 2022 $1,302,000 30 Sep 2022 10-Q 10 Nov 2022 2022 Q3
Q2 2022 $999,000 30 Jun 2022 10-Q 10 Aug 2022 2022 Q2
Q1 2022 $1,159,000 31 Mar 2022 10-Q 11 May 2022 2022 Q1
Q4 2021 $0 31 Dec 2021 10-K 22 Mar 2023 2022 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.